Skip to content

Role of Homeopathy in the treatment of Periodontitis with Diabetes

Investigating the Impact of Homeopathic Therapy on Clinical, Metabolic Control, and Systemic Inflammatory Markers in Periodontitis Patients with Diabetes: A Randomized Multi-Arm Clinical Trial. - Not applicable

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085934
Enrollment
400
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Group 2 (NSPT + IH): Receives Individualized homeopathic medicine in centesimal potency customized to each patient, along with non-surgical periodontal therapy (NSPT) comprising of scal

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals aged 30 to 70 years, diagnosed with Stage II, III & IV Periodontitis 2. HbA1c eligibility to include both controlled or uncontrolled diabetic patients. 3. No modification in diabetic medication in the last three months before or during the study.

Exclusion criteria

Exclusion criteria: 1. Patients affected with any systemic conditions known to exert effects of any kind in the study or on the assessed parameters. 2. Patients diagnosed with type 1 diabetes 3. Current Smokers and recent former smokers. 4. Pregnant and lactating females. 5 Any form of periodontal therapy in the previous 6 months. 6. Use of any antimicrobials in the last three months. 7. Any other infections (e.g., Common cold, influenza, ENT infections, etc.) may affect any change in the considered study parameters. 8. Patients undergoing or have undergone radiation therapy in the recent past. 9. Long-standing infections of any kind and patients on chemotherapy 10. Uncontrolled hypertension.

Design outcomes

Primary

MeasureTime frame
Bleeding on Probing (BOP) Probing Pocket Depth (PPD) Clinical Attachment Level (CAL) Timepoint: baseline, month1, month 3 & month6

Secondary

MeasureTime frame
Fasting blood glucose levels and HbA1cTimepoint: Baseline, month1, month3, month6;Analysis of specific inflammatory biomarkers (IL-1Beta, IL-6, TNF-alpha, IL-17, and MMP-8) in saliva samplesTimepoint: Baseline,month1, month 3 & month6 ,;Measurement of PINK1/PARKIN proteins in serum samples to explore their levels and any alterations between intervention and control groupsTimepoint: Baseline, month1, month 3 & month6;To assess the Oral Health-Related Quality of Life (OHRQoL), using Oral Health Impact Profile (OHIP).Timepoint: Baseline, month1, month 3 & month6

Countries

India

Contacts

Public ContactDr Varanasi Roja

SRM Kattankulathur Dental College and Hospital , SRM IST, Kattankulathur, Tamil Nadu, India

vivekn@srmist.edu.in9444360303

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026